Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation - Wikidata - awgldk - TriplyDB

Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation

Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation

http://www.wikidata.org/entity/Q34389668

about

The neurobiology of the Prader-Willi phenotype of fragile X syndrome Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.A de novo t(10;19)(q22.3;q13.33) leads to ZMIZ1/PRR12 reciprocal fusion transcripts in a girl with intellectual disability and neuropsychiatric alterations Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.From FMRP function to potential therapies for fragile X syndrome.Modeling fragile X syndrome in the Fmr1 knockout mouse Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression.Lithium: a promising treatment for fragile X syndrome.Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome.Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome.Discrimination learning and attentional set formation in a mouse model of Fragile X.Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders Neuroprotective action of lithium in disorders of the central nervous system.The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice.Therapeutic potential of metabotropic glutamate receptor modulators.R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.Comprehensive motor testing in Fmr1-KO mice exposes temporal defects in oromotor coordination Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle.Unaltered hormonal response to stress in a mouse model of fragile X syndrome The cyclic AMP phenotype of fragile X and autism Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.Deficient Sleep in Mouse Models of Fragile X Syndrome.Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis.Negative Effects of Chronic Rapamycin Treatment on Behavior in a Mouse Model of Fragile X Syndrome.

P2860

Q28078294-BA4977AB-B920-4064-A256-303D43F96ABF Q28261563-1BD6B9F9-5D0B-4E87-B18F-A8E39C37EC68 Q28771505-71BE826A-EC7E-4D71-B9DE-0E31D44E1F31 Q30387508-AA6814A0-434D-446C-9CEC-12690646F7E7 Q30403591-60DF77BE-BEC4-4255-92FD-60651AF89AA4 Q30410502-41D8F67E-3714-4D2D-8883-E3DEC1610E21 Q30420595-5B0D0B10-709E-42AC-B7DB-B75098D9B313 Q30457688-7462BC38-AB88-436E-99B0-DF6A927C4326 Q30488395-8B0845D1-983F-4C0F-8397-58F45E72B82A Q30500501-ECAA72A8-977D-462C-9CD2-FA1F33DC5C7A Q33562835-41C1E098-22E3-4EEB-A0D5-6196696661E1 Q33607288-EFA3AC90-5AFE-4DA2-A3DA-61C61FC19573 Q33721411-9A63C3E4-ECC8-4C55-B25A-DC29D5AEA1DB Q33777951-1E3D0CC9-01E0-4E46-AF9D-5CB32084BA5F Q33914148-39B121AF-7800-40F4-BCA7-5CE8C695D81A Q34973856-C87B233F-1DB2-4A10-A67E-6CA21DF30A81 Q35027861-0D49D65B-049C-4BD7-AEFE-B21205D21F1B Q35125117-0891B775-F24B-408E-BED6-A2FE0F10F78F Q35148962-6379D19F-D30D-4201-945B-3344FAE25DB0 Q35197096-3032B9DC-D0AA-49C3-89D2-9C6833DE51CD Q35212429-C44E3BD3-1677-45DD-B75C-7D70D9622D39 Q35234080-C2F1ABD1-171D-49DF-BD24-50A3AB1D0DD0 Q35243625-CF79AC6C-81C9-4477-AE9D-4FF724F5FA94 Q35778704-5D2A3B3C-5041-4E19-B61E-9B6C4FE08A50 Q36077206-2B475804-4B31-40FC-8F31-3E1183CDC8A1 Q36920700-9CE89435-89AB-4D3B-8EDB-E5A8C39B0776 Q36990260-7B02A677-0669-48F3-93E2-AAE594CFF4D1 Q37041957-85AB44C0-9BC2-4B1E-818C-F153CA4C5BF2 Q37097136-8C30AC6A-414A-4663-B95C-C6358F556CAD Q37213114-FC878FA5-B502-40F8-976E-C2C56B1D7104 Q37642816-FFC46B28-D726-420F-B4E3-71386F8E3E3B Q40295553-20954457-185D-4D48-951B-F05CD0DF846E Q41619835-F5C0627C-E80C-4247-8E68-8C6A4718268F Q42620608-B09EB561-9322-499B-A676-8CB4687165A5 Q45213302-C0668269-3325-42BE-9B95-367E06AE79B1 Q47551363-2E6F9F4C-0822-44C1-B92B-8F51AE4CD4B5

P2860

Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation

http://www.wikidata.org/entity/Q34389668

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Increased rates of cerebral gl ...... f fragile X mental retardation

@ast

Increased rates of cerebral gl ...... f fragile X mental retardation

@en

Increased rates of cerebral gl ...... f fragile X mental retardation

@nl

type

label

Increased rates of cerebral gl ...... f fragile X mental retardation

@ast

Increased rates of cerebral gl ...... f fragile X mental retardation

@en

Increased rates of cerebral gl ...... f fragile X mental retardation

@nl

prefLabel

Increased rates of cerebral gl ...... f fragile X mental retardation

@ast

Increased rates of cerebral gl ...... f fragile X mental retardation

@en

Increased rates of cerebral gl ...... f fragile X mental retardation

@nl

P1433

Q34389668-EE162EA9-0EDC-48EE-A0AF-6A5D9F7888B3

P1476

Q34389668-C8FD7AAF-2AA8-4C17-BE0E-49952404C36E

P2093

Q34389668-658A40AB-CC21-4719-92FC-B3934FE94B6D

Q34389668-7FC2D353-88FA-46E6-AC3C-202783903336

Q34389668-EDC789E0-B44F-45E1-953E-F281F3FB099E

P2860

Q34389668-025C1912-0B2E-45F2-9DC6-73A38D6A59C3

Q34389668-1884D17F-2687-4FDE-A675-A1549876B73A

Q34389668-1F79F813-3848-4C0B-A3DE-F07E3C0CFC42

Q34389668-277DB4B3-16A0-4EFA-A6E3-5C11285A3BF0

Q34389668-2A29527E-49C9-4BC5-B298-253ED9503450

Q34389668-2F00CA5E-372E-47FA-A157-B9CF21DF84D2

Q34389668-3B3CD3E9-DE7A-4F79-B75C-B805D2801804

Q34389668-489667EA-FECC-4696-84D6-BA76D65A1AA4

Q34389668-4D248C50-69DD-4E1D-81FE-C21C5C0B97CC

Q34389668-6061CD73-79DF-4FEF-94E8-0460FB216EAE

P304

Q34389668-270728D4-F331-427F-B6B6-58F12D967A48

P31

Q34389668-6ED12DF7-BE06-4DD1-B365-5CA70B7EECE9

P356

Q34389668-09E8E222-4537-4DF7-9727-BCD8E76233F3

P407

Q34389668-1E60D1A0-E71A-417D-81B5-F174DAB8B9E5

P433

Q34389668-9BAA02EF-6AFB-4336-9BFE-3ABCAF89D14C

P478

Q34389668-FFA0A271-1E35-4ADB-BEF4-E32BB0F1140E

P577

Q34389668-F111A67A-5775-4FC6-A7E2-33A827C2FA98

P5875

Q34389668-77A37B92-58C4-482A-8605-E068FF3299C3

P698

Q34389668-43683C95-5165-4D21-BE2A-CE3D3F78CF7E

P932

Q34389668-B187B5D8-CCDF-4524-9CE3-DE2F47EA972D

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Increased rates of cerebral gl ...... f fragile X mental retardation

@en

P2093

Carolyn Beebe Smith

http://www.w3.org/2001/XMLSchema#string

Julia Kang

http://www.w3.org/2001/XMLSchema#string

Mei Qin

http://www.w3.org/2001/XMLSchema#string

P2860

FMR1 protein: conserved RNP family domains and selective RNA binding

Altered synaptic plasticity in a mouse model of fragile X mental retardation

Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice.

Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits

Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation

Evidence that fragile X mental retardation protein is a negative regulator of translation

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes

Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry disease

The fragile X mental retardation protein inhibits translation via interacting with mRNA

P304

15758-15763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.242377399

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11039105

http://www.w3.org/2001/XMLSchema#string

P698

12427968

http://www.w3.org/2001/XMLSchema#string

P932

137789

http://www.w3.org/2001/XMLSchema#string